Outcomes-based contracting in multiple sclerosis disease-modifying therapies: Payer and manufacturer perspectives

Authors
Category Primary study
JournalJournal of Managed Care and Specialty Pharmacy
Year 2019
This article has no abstract
Epistemonikos ID: 7c7aca1a2871eca7b8c965cd1be3a9f34065df4d
First added on: Feb 11, 2025